Search clinical trials for: LCQ908A

Total 12 results

Novartis Pharmaceuticals

Completed

Pharmacokinetics of LCQ908 in Patients With Hepatic Impairment

Hepatic Impairment

United States
Novartis Pharmaceuticals

Terminated

Extension to a Randomized, Double-blind, Placebo Controlled Study of LCQ908 in Subjects With Familial Chylomicronemia Syndrome.

Familial Chylomicronemia Syndrome (FCS) (HLP Type I)

South Africa, Germany, United Kingdom, France, United States, Canada, Netherlands
Novartis Pharmaceuticals

Completed

Pharmacokinetics of LCQ908 in Patients With Renal Impairment

Renal Impairment

United States
Novartis Pharmaceuticals

Completed

Safety, Tolerability,Pharmacokinetics(PK)and Pharmacodynamics(PD)Assessment of LCQ908 in Patients With Severe Hypertriglyceridemia

Hyperlipoproteinemia

Canada
Novartis Pharmaceuticals

Completed

A Randomized, Double-blind, Placebo Controlled Study to Assess Efficacy, Safety and Tolerability of LCQ908 in Subjects With Familial Chylomicronemia Syndrome

Familial Chylomicronemia Syndrome (FCS)

South Africa, Spain, France, Germany, United Kingdom, United States, Canada, Netherlands
Novartis Pharmaceuticals

Terminated

Efficacy of LCQ908 on Cardiovascular Risk

Coronary Artery Disease | Hypertriglyceridemia

United States
Novartis Pharmaceuticals

Terminated

A Two Week Dosing Study to Determine the Safety and Antiviral Activity of LCQ908 in Hepatitis C Patients

Hepatitis C

New Zealand
Novartis Pharmaceuticals

Completed

Study to Assess the Efficacy, Safety and Tolerability of LCQ908 in NAFLD Patients

Non-alcoholic Fatty Liver Disease (NAFLD)

United States
Novartis Pharmaceuticals

Completed

A Pilot Study to Assess the Efficacy and Safety of LCQ908 Alone and in Combination With Fenofibrate or Lovaza® in Patients With Severe Hypertriglyceridemia

Non Familial Chylocmicronemia Syndrome (Non-FCS)

United States, Canada, Russian Federation
Novartis Pharmaceuticals

Completed

A 12 Week Study in Patients With Type 2 Diabetes Mellitus (T2DM)

Type 2 Diabetes Mellitus

Canada, United States, Italy, Poland, Puerto Rico
University of Notre Dame Australia
St Vincent's Hospital, Sydney

Completed

Prevalence and Predictors of Prolonged Post-surgical Opioid Use: a Prospective Observational Cohort Study

Pain, Postoperative | Surgery | Opioid-related Disorders | Opiate Addiction | Opioid Use Disorders | Post-operative Complications

Australia
Pulmotect, Inc.
WCCT Global

Completed

Effect of Pre-Treatment With Cromolyn or Albuterol on Response to PUL-042 Inhalation Solution (PUL-042)

Healthy

United States

Search clinical trials for: LCQ908A

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Paraguay

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations